Vimarsana
Biggest News Aggregation in the World

Page 11 - Monitoring Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Monitoring Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Monitoring Management Today - Breaking & Trending Today

Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3® - Vimarsana News

Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3®

Article content Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARDS). 1 To gauge the impact, the researchers used the Masimo Root ® Patient Monitoring and Connecti...

New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy - Vimarsana News

New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy

Masimo New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy Monday, March 15, 2021 1:12PM IST (7:42AM GMT)   Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.” 1 EMMA ® provides seamless mainstream capnography for patients of al...

New Study Evaluates the Ability of Masimo EMMA Capnography to Assess the Respiratory Status of Children With Tracheostomy - Vimarsana News

New Study Evaluates the Ability of Masimo EMMA Capnography to Assess the Respiratory Status of Children With Tracheostomy

Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.” 1 EMMA ® provides seamless mainstream capnography for patients of all ages in a compact, easily portable device. The device requires no routine calibration and minimal warm-up time, with accurate end-tidal carbon dioxide (EtCO 2) and respiration rat...

Masimo Announces CE Marking of the Rad-G™ with Temperature - Vimarsana News

Masimo Announces CE Marking of the Rad-G™ with Temperature

Masimo Announces CE Marking of the Rad-G™ with Temperature Tuesday, March 2, 2021 1:26PM IST (7:56AM GMT)   Neuchatel, Switzerland:   Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET ® pulse oximetry, respiration rate from the pleth (RRp ®), and other important parameters alongside clinical-grade, non-contact infrared thermometry. With its long-lasting rechargeable battery, robust rubber casing, light weight, and integrated noninv...

Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc - Vimarsana News

Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc

Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc Masimo (NASDAQ: MASI) today announced that it has successfully completed the acquisition of the LiDCO Group Plc, a leading provider of advanced hemodynamic monitoring solutions (LiDCO). The Company completed the acquisition of 100% of LiDCO on February 2, 2021. LiDCO was founded in 1991, launched its first product in 1999, and began trading on the AIM submarket of the London Stock Exchange in 2001. On Janu...